Finance

Lists
VREX:NASDAQ
Varex Imaging Corp
$18.48
+0.05%
(+0.010) 1D
$18.48
0.00% (0.00)
After hours
Closed: Sep 22, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for VREX...
Open
$18.51
High
$18.51
Low
$18.47
Mkt. cap
778.90M
Avg. vol.
1.33M
Volume
687.76K
P/E ratio
35.36
52-wk high
$18.63
52-wk low
$9.09
EPS
$0.52
Beta
0.96
Shares outstanding
42.15M
No. of employees
2K
Open
$18.51
High
$18.51
Low
$18.47
Mkt. cap
778.90M
Avg. vol.
1.33M
Volume
687.76K
P/E ratio
35.36
52-wk high
$18.63
52-wk low
$9.09
EPS
$0.52
Beta
0.96
Shares outstanding
42.15M
No. of employees
2K
News stories
From web sources and news partners
About Varex Imaging Corp
CEO-
Employees2.5K
Founded2016
HeadquartersSalt Lake City, Utah, United States
SectorMedical device
Websitevareximaging.com
Analyst ratings
Based on 4 analysts giving stock ratings to VREX in the past 3 months
Hold
Buy
0
Hold
4
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for VREX in the last 3 months.
Highest
Current $18.48
$19.00 (+2.81%)
Average
$18.93 (+2.44%)
Lowest
$18.90 (+2.27%)
Analyst
Recommendation
Action
Price target
Projected
Date
Lawrence Solow
CJS Securities
Hold
Downgraded
$18.90
+2.3%
08/17/2026
Suraj Kalia
Oppenheimer
Hold
Downgraded
$18.90
+2.3%
08/11/2026
Anderson Schock
B. Riley Securities
Hold
Downgraded
$18.90
+2.3%
08/10/2026
James Sidoti
Sidoti
Hold
Downgraded
$19.00
+2.8%
08/10/2026
Last report
Aug 10, 2026
Fiscal period
Q3 2026
EPS / Est. (USD)
$0.31 / $0.20
+56.57%beat
Revenue / Est. (USD)
210.50M / 215.50M
-2.32%miss
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Oct 2025
Jan 2026
Apr 2026
Jul 2026
Revenue
228.90M
209.60M
216.00M
210.50M
Cost of goods sold
151.10M
139.80M
143.40M
133.80M
Cost of revenue
151.10M
139.80M
143.40M
133.80M
Research and development expenses
24.20M
21.70M
22.20M
23.30M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
34.00M
32.70M
36.00M
30.60M
Operating expense
58.20M
54.40M
58.20M
53.90M
Total operating expenses
209.30M
194.20M
201.60M
187.70M
Operating income
19.60M
15.40M
14.40M
22.80M
Other non operating income
6.70M
-1.10M
-2.70M
-
EBT including unusual items
14.10M
3.80M
-6.40M
16.20M
EBT excluding unusual items
14.10M
3.80M
-6.40M
15.60M
Income tax expense
1.90M
1.40M
1.60M
300.00K
Effective tax rate
13.48%
36.84%
-25.00%
1.85%
Other operating expenses
-
-
-
-
Net income
12.20M
2.30M
-8.10M
15.70M
Net profit margin
5.33%
1.10%
-3.75%
7.46%
Earnings per share
0.37
0.19
0.21
0.31
Interest and investment income
1.00M
600.00K
400.00K
900.00K
Interest expense
-7.90M
-7.90M
-17.20M
-5.80M
Net interest expenses
-6.90M
-7.30M
-16.80M
-4.90M
Depreciation and amortization charges
-
-
-
-
EBITDA
26.30M
22.20M
21.20M
29.80M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps